Šīs tīmekļa vietnes satura kvalitātes uzlabošanai un pielāgošanai lietotāju vajadzībām tiek lietotas sīkdatnes - tai skaitā arī trešo pušu sīkdatnes. Turpinot lietot šo vietni Jūs piekrītat sīkdatņu lietošanai.
Third Quarter 2012 Investor Conference Webinar
Emitents Olainfarm, AS (213800WCG52W62ENOP27)
Veids Citi
Valoda EN
Statuss Publicēts
Versija
Datums 2012-12-11 09:41:12
Versijas komentārs
Teksts

 

Third Quarter 2012 Investor Conference Webinar


On December 10 AS „Olainfarm” organized its third quarter 2012 Investor Conference Online Webinar for investors. During the
webinar the member of the management board of AS „Olainfarm” Salvis Lapiņš analysed the financial results of third quarter
2012 and informed about the company’s future activities.


As Salvis Lapiņš informed during the webinar AS “Olainfarm” budget forecast for 2012 is 48 M LVL with net profit 8,6 M LVL.
Based on 9 months results, current turnover has reached 73.3% of target and net profit – 74.2%, therefore company is positive
about reaching, and even exceeding its budget forecast by the end of the year.


Answering the questions sent in by the investors, Salvis Lapiņš informed that AS “Olainfarm” is also actively working to
expand on Turkish and Polish markets. Also the daughter company - “Olaines enerģija” has recently (from the beginning of
December, 2012) started to produce energy for AS “Olainfarm” production facilities and AS “Olainfarm” is no longer purchasing
gas from “Latvijas gāze”. However it is too early to judge on potential financial gains.
 

The recorded “Olainfarm” webinar is available online: http://ej.uz/OLFdecember_REC, and the presentation, demonstrated
during the webinar, can be found in the previously published AS “Olainfarm” announcement:
 https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=533560&messageId=656679.

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get
 information on the next webinar!

A/s Olainfarm is one of the biggest pharmaceutical companies in Latvia with 40 years of experience in production of
medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and
effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more
than 30 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia. 


Information prepared by:
Salvis Lapins
Member of the Board
A/s „Olainfarm”
Tel: +371 6 7013 717
Cell: +371 2 6448 873

Pielikumi